ESMO 2017 Annals of Oncology Abstract Book

616 Pages·2017·8.66 MB·English

Annals of
Oncology
Abstract Book of the
42nd ESMO Congress (ESMO 2017)
Madrid, Spain
8–12 September 2017
GuestEditors: ESMO2017CongressScientificCommittee
Annals of Oncology
Official Journal of the European Society for Medical Oncology and
the Japanese Society of Medical Oncology
Editor-in-chief S.Pignata,Naples,Italy BioTechnologies
E.Mardis,St.Louis,Missouri,USA
J.-C.Soria,Villejuif,France Melanoma
G.Long,Sydney,Australia Onco-Immunology
Associateeditors Hematologicalmalignancies G.Coukos,Lausanne,Switzerland
Urogenitaltumors K.Tsukasaki,Saitama,Japan A.Snyder,NewYork,NewYork,USA
G.Attard,Sutton,UK P.L.Zinzani,Bologna,Italy Neuro-oncology
M.DeSantis,Birmingham,UK Supportivecare A.Ibdaih,Paris,France
Gastrointestinaltumors K.Jordan,Heidelberg,Germany
Statistics
D.Arnold,Lisbon,Portugal Epidemiology M.Buyse,Brussels,Belgium
A.Cervantes,Valencia,Spain P.Boffetta,NewYork,NewYork,USA
J.Tabernero,Barcelona,Spain P.Lagiou,Athens,Greece Molecularandsurgicalpathology
Breasttumors Sarcomaandclinicalpharmacology I.I.Wistuba,Houston,Texas,USA
F.Andre´,Villejuif,France
O.Mir,Villejuif,France
C.Sotiriou,Brussels,Belgium AnnalsofOncologyonline
Earlydrugdevelopment C.Ferte´,Villejuif,France
Thoracictumors
J.-C.Soria,Villejuif,France
T.Mitsudomi,Osaka,Japan Industrycorner:perspectivesandcontroversies
J.F.Vansteenkiste,Leuven,Belgium Preclinicalandexperimentalscience K.Dhingra,NewYork,NewYork,USA
T.U.E.Helleday,Stockholm,Sweden
Headandnecktumors
A.T.C.Chan,Shatin,HongKong Precisionmedicine Editorsemeriti
E.Cohen,SanDiego,California,USA C.Swanton,London,UK
F.Cavalli,Bellinzona,Switzerland
Gynecologicaltumors Bioinformatics D.J.Kerr,Oxford,UK
B.Monk,Phoenix,Arizona,USA N.McGranahan,London,UK J.B.Vermorken,Edegem,Belgium
Editorialboard
M.S.Aapro,Genolier,Switzerland A.Grothey,Rochester,Minnesota,USA S.I.Ou,Orange,California,USA
M.Alsina,Barcelona,Spain S.Halabi,Durham,NorthCarolina,USA X.Paoletti,Paris,France
Y.Ando,Nagoya,Japan D.G.Haller,Philadelphia,Pennsylvania,USA C.Pezaro,Melbourne,Australia
P.Autier,Lyon,France K.Hotta,Okayama,Japan P.Pfeiffer,Odense,Denmark
H.A.AzimJr,Brussels,Belgium I.Hyodo,Tsukuba,Japan S.Postel-Vinay,Villejuif,France
I.Barnes,Oxford,UK M.Ignatiadis,Brussels,Belgium A.Psyrri,NewHaven,Connecticut,USA
J.Baselga,NewYork,USA D.H.Ilson,NewYork,NewYork,USA D.Quinn,LosAngeles,California,USA
J.Bellmunt,Boston,Massachusetts,USA H.Iwata,Aichi,Japan S.S.Ramalingam,Atlanta,Georgia,USA
B.Besse,Villejuif,France F.Janku,Houston,Texas,USA M.Reck,Grosshansdorf,Germany
J.Beyer,Zurich,Switzerland N.Katsumata,Kawasaki,Japan B.Rini,Cleveland,Ohio,USA
P.Bierman,Omaha,Nebraska,USA N.Kiyota,Kobe,Japan R.Rosell,Badalona,Spain
C.Bokemeyer,Hamburg,Germany C.LaVecchia,Milan,Italy A.D.Roth,Geneva,Switzerland
N.Boku,Tokyo,Japan P.N.JrLara,Sacramento,California,USA R.Salazar,Barcelona,Spain
E.Bria,Verona,Italy J.M.Larkin,London,UK M.Scartozzi,Ancona,Italy
E.F.Burgess,Charlotte,USA S.Loi,Melbourne,Australia N.Schmitz,Hamburg,Germany
P.G.Casali,Milan,Italy S.Loibl,Neu-Isenburg,Germany H.-J.Schmoll,Halle,Germany
F.Ciardiello,Naples,Italy F.Lordick,Leipzig,Germany I.Sekine,Tsukuba,Japan
A.Comandone,Turin,Italy Y.Loriot,Villejuif,France Q.Shi,Rochester,Minnesota,USA
P.G.Corrie,Cambridge,UK D.Lorusso,Milan,Italy A.F.Sobrero,Genoa,Italy
G.Curigliano,Milan,Italy S.Lutzker,SanFrancisco,California,USA G.Sonpavde,Birmingham,Alabama,USA
A.DiLeo,Prato,Italy T.Macarulla,Barcelona,Spain S.Takahashi,Tokyo,Japan
R.Dienstmann,Barcelona,Spain M.Martin,Madrid,Spain M.Toi,Kyoto,Japan
T.Dorff,LosAngeles,California,USA S.Matsui,Tokyo,Japan R.Turck,Montclair,NewJersey,USA
H.Dosaka-Akita,Sapporo,Japan J.Maurel,Barcelona,Spain B.A.VanTine,St.Louis,Missouri,USA
A.Eniu,Cluj-Napoca,Romania G.McArthur,Melbourne,Australia E.Vilar,Houston,Texas,USA
T.Fenske,Milwaukee,Wisconsin,USA S.Michiels,Villejuif,France Y.-L.Wu,Guangzhou,China
S.Galbraith,Cambridge,UK H.Minami,Kobe,Japan J.C.-H.Yang,Taipei,Taiwan
G.Giamas,Brighton,UK Y.Nishimura,Osaka-Sayama,Japan S.Yano,Kanazawa,Japan
R.Glynne-Jones,Northwood,UK K.Nishio,Osaka-Sayama,Japan T.Yoshino,Chiba,Japan
B.-C.Goh,Singapore M.Ogura,Gifu,Japan A.X.Zhu,Boston,Massachusetts,USA
A.Goldhirsch,Milan,Italy A.Ohtsu,Kashiwa,Japan
P.Grimison,Sydney,Australia I.Okamoto,Fukuoka,Japan
Executiveeditor:LewisRowett
Editorial office: Vanessa Marchesi, Paola Minotti Bernasconi, Giovannella Porcu, Annals of Oncology, Via Luigi Taddei 4, CH-6962
Viganello-Lugano,Switzerland
AnnalsofOncologyiscoveredinC.A.B.International,CurrentClinicalCancer,CurrentContents/ClinicalMedicineVR,CurrentContents/Life
Sciences,ElsevierBIOBASE/CurrentAwarenessinBiologicalSciences,EMBASE/ExcerptaMedica,IBIDS,IndexMedicus/MEDLINE,The
InternationalMonitorinOncology,MedicalDocumentationService,ScienceCitationIndexVRandScienceCitationIndexExpanded.
Subscriptions Piscataway,NJ08854.PeriodicalspostagepaidatPiscataway,NJandadditional
mailingoffices.
AsubscriptiontoAnnalsofOncologycomprises12issuesplussupplementsin
eachvolume.Pricesincludepostage,andforsubscribersoutsidetheUKdeliveryis SubscriptionrecordsaremaintainedatOxfordUniversityPress,Oxford,UK.
byStandardAir.
Supplements,reprintsandcorporatesales
AnnualSubscriptionRate(Volume28,12issues,2017)
For requests from industry and companies regarding supplements, bulk article
Institutional-Academic/Nonprofitonly reprints,sponsoredsubscriptions,translationopportunitiesforpreviouslypublished
PrintandOnline£1655.00/$3310.00/f2482.00 material,andcorporateonlineopportunities,pleaseemail:[email protected],
OnlineOnly£1204.00/$2408.00/f1806.00 fax:þ44(0)1865353774orvisithttp://www.oupmediainfo.com/#!/reprints-eprints.
PrintOnly£1525.00/$3050.00/f2288.00
Institutional-Corporate Permissions
PrintandOnline£2069.00/$4137.00/f3103.00
Forinformationonhowtorequestpermissionstoreproducearticles/information
OnlineOnly£1505.00/$3010.00/f2258.00
from this journal, please visit https://academic.oup.com/journals/pages/access_
PrintOnly£1906.00/$3813.00/f2860.00
purchase/rights_and_permissions.
Personal
PrintandOnline£1237.00/$2476.00/f1856.00 Advertising
Pleasenote:US$rateappliestoUS&Canada,EurosappliestoEurope,UK£
Advertising,insertsandartworkenquiriesshouldbeaddressedtoAdvertisingand
appliestoUKandRestofWorld.
SpecialSales,OxfordJournals,OxfordUniversityPress,GreatClarendonStreet,
Theremaybeothersubscriptionratesavailable,foracompletelistingpleasevisit Oxford, OX2 6DP, UK. Tel: þ44 (0)1865 354767; Fax þ44 (0)1865 353774;
https://academic.oup.com/annonc/subscribe E-mail:[email protected]
Full prepayment, in the correct currency, is required for all orders. Orders are
Environmentalandethicalpolicies
regardedasfirmandpaymentsarenotrefundable.Subscriptionsareacceptedand
enteredonacompletevolumebasis.ClaimscannotbeconsideredmorethanFOUR OxfordJournals,adivisionofOxfordUniversityPress,iscommittedtoworking
monthsafterpublicationordateoforder,whicheverislater.Allsubscriptionsin withtheglobalcommunitytobringthehighestqualityresearchtothewidestpos-
CanadaaresubjecttoGST.SubscriptionsintheEUmaybesubjecttoEuropean sibleaudience.OxfordJournalswillprotecttheenvironmentbyimplementing
VAT.Ifregistered,pleasesupplydetailstoavoidunnecessarycharges.Forsubscrip- environmentally friendly policies and practices wherever possible. Please see
tionsthatincludeonlineversions,aproportionofthesubscriptionpricemaybesub- https://academic.oup.com/journals/pages/about_us/ethical_policies for further
jecttoUKVAT.Personalratesubscriptionsareonlyavailableifpaymentismadeby informationonenvironmentalandethicalpolicies.
personalchequeorcreditcardanddeliveryistoaprivateaddress.
The current year and two previous years’ issues are available from Oxford Notice
Journals. Previous volumes can be obtained from the Periodicals Service
The content of the abstracts contained in this Abstract Book is subject to an
Company at http://www.periodicals.com/oxford.html or Periodicals Service
embargo.
Company,11MainStreet,Germantown,NY12526,USA.Email:psc@periodicals.
com.Tel:[phone].Fax:[phone] AbstractsacceptedforpresentationatESMO2017asProfferedPaper(oralpre-
sentation),PosterDiscussionandPosterwillbepublishedonlineontheESMO
Forfurtherinformation,pleasecontact:JournalsCustomerService
websiteat00:05CESTonThursday,31August2017.
Department,OxfordUniversityPress,GreatClarendonStreet,OxfordOX26DP,
UK.Email:[email protected](andanswerphoneoutsidenormalwork- Late-breakingabstractsandabstractsselectedforthePressProgrammewillbe
inghours):þ44(0)1865353907.Fax:þ44(0)1865353485.IntheUS,please madepublicat00:05CEST(CentralEuropeanSummerTime)onthedayofthe
contact:JournalsCustomerServiceDepartment,OxfordUniversityPress,2001 officialCongresssessionduringwhichtheyarepresented.
EvansRoad,Cary,NC27513,USA.Email:[email protected](andanswer-
phoneoutsidenormalworkinghours):8008527323(toll-freeinUSA/Canada). Disclaimer
Fax:[phone].InJapan,pleasecontact:JournalsCustomerService,Oxford
Noresponsibilityisassumedbytheorganizersforanyinjuryand/ordamagetoper-
UniversityPress,4-5-10-8FShiba,Minato-ku,Tokyo108-8386,Japan.Tel.þ813
sonsorpropertyasamatterofproductsliability,negligenceorotherwise,orfrom
54445858.Fax.þ81334542929.E-mail:[email protected]
anyuseoroperationofanymethods,products,instructionsorideascontainedinthe
DOI:ForinformationaboutDOIsandtoresolvethem,pleasevisithttp://www. materialherein.Becauseoftherapidadvancesinmedicalsciences,werecommend
doi.org thatindependentverificationofdiagnosesanddrugdosagesshouldbemade.
Methodsofpayment.(i)Cheque(payabletoOxfordUniversityPress,toOxford Everyefforthasbeenmadetofaithfullyreproducetheabstractsassubmitted.
UniversityPress,CashiersOffice,GreatClarendonStreet,OxfordOX26DP,UK) However,noresponsibilityisassumedbytheorganizersforanyomissionsor
inGB£Sterling(drawnonaUKbank),US$Dollars(drawnonaUSbank),or misprints.
EUfEuros.(ii)BanktransfertoBarclaysBankPlc,OxfordGroupOffice,Oxford
VCTheEuropeanSocietyforMedicalOncology2017
(banksortcode20-65-18)(UK),overseasonlySwiftcodeBARCGB22(GB£
Sterling to account no. 70299332, IBAN GB89BARC20651870299332; US$ Allrightsreserved;nopartofthispublicationmaybereproduced,storedina
Dollarstoaccountno.66014600,IBANGB27BARC20651866014600;EUfEuros retrievalsystem,ortransmittedinanyformorbyanymeans,electronic,mechani-
toaccountno.78923655,IBANGB16BARC20651878923655).(iii)Creditcard cal,photocopying,recording,orotherwisewithoutpriorwrittenpermissionofthe
(Mastercard,Visa,SwitchorAmericanExpress). Publishers,oralicencepermittingrestrictedcopyingissuedintheUKbythe
CopyrightLicensingAgencyLtd,90TottenhamCourtRoad,LondonWIP9HE,
AnnalsofOncology(ISSN0923-7534)ispublishedmonthlybyOxfordUniversity
orintheUSAbytheCopyrightClearanceCenter,222RosewoodDrive,Danvers,
Press,Oxford,UKanddistributedintheUSAbyCentralMailingServicesc/o
MA01923.
UKPWorldwide,1637SteltonRoadB2,Piscataway,NJ08854.TheUSannual
printsubscriptionorpriceis$3310.00.AirfreightandmailingintheUSAbyagent TypesetbyCenveoPublisherServices,Bangalore,India.
namedCentralMailingServicesc/oUKPWorldwide,1637SteltonRoadB1-2, PrintedbyBellandBainLtd.,Glasgow,UK.
Annals of
Oncology
Official Journal of the
European Society for Medical
Oncology
Volume 28, 2017 Supplement 5
AbstractBookofthe
42ndESMOCongress(ESMO2017)
Madrid,Spain
8–12September2017
GuestEditors:
ESMO2017CongressScientificCommittee
Annals of Oncology
Official Journal of the European Society
for Medical Oncology
Volume 28, 2017 Supplement 5
Abstract Bookofthe 42ndESMO Congress(ESMO2017)
8–12 September 2017, Madrid,Spain
AboutESMO
AboutEACR
ESMOExecutiveBoard
EACRExecutiveBoard
ESMO2017CongressOfficers
Acknowledgements
Submittedabstracts
Basicscience v1-v21
Biomarkers v22-v42
Breastcancer,earlystage v43-v67
Breastcancer,locallyadvanced v68-v73
Breastcancer,metastatic v74-v108
CNStumours v109-v121
Developmentaltherapeutics v122-v141
Endocrineandneuroendocrinetumours v142-v157
Gastrointestinaltumours,colorectal v158-v208
Gastrointestinaltumours,non-colorectal v209-v268
Genitourinarytumours,prostate v269-v294
Genitourinarytumours,non-prostate v295-v329
Gynaecologicalcancers v330-v354
Haematologicalmalignancies v355-v371
Headandneckcancer,excludingthyroid v372-v394
Healtheconomics v395-v402
Immunotherapyofcancer v403-v427
Melanomaandotherskintumours v428-v448
Newdiagnostictools v449-v452
NSCLC,earlystage v453-v456
NSCLC,locallyadvanced v457-v459
NSCLC,metastatic v460-v496
Palliativecare v497-v501
Preventionandscreening v502-v506
Psycho-oncology v507-v510
Publichealth v511-v520
Sarcoma v521-v538
SCLC v539-v542
Supportivecare v543-v567
Thoracicmalignancies,other v568-v572
Translationalresearch v573-v594
Tumourbiologyandpathology v595-v604
Note:Abstractsuffixes
“O”indicatesasubmittedabstractacceptedforProfferedPaper(oral)presentation
“PD”indicatesasubmittedabstractacceptedforPosterDiscussionpresentation
“P”indicatesasubmittedabstractacceptedforPosterPresentation
“TiP”indicatesasubmittedabstractacceptedforPosterPresentation,TrialinProgress
_PRindicatesasubmittedabstractselectedforinclusionintheESMOPressProgramme
Volume28|Supplement5|September2017
The European Society for Medical Oncology (ESMO)
ESMO is the leading professional organisation for medical oncology, with the overarching goal of improving outcomes for cancer
patientseverywhere.Wearethesocietyofreferenceforoncologyeducationandinformation,andarecommittedtosupportingour
memberstodevelopandadvanceinafast-evolvingprofessionalenvironment.
Foundedin1975,ESMOhasEuropeanrootswithaglobalreach:wewelcomeoncologyprofessionalsfromaroundtheworld.Wearea
homeforalloncologystakeholders,connectingprofessionalswithdiverseexpertiseandexperience,andspeakingwithonevoicefor
our discipline. Our educationandinformationresourcessupportan integrated multi-professional approachtocancer care, froma
medicaloncologyperspective.Weseektoeraseboundariesincancercare,whetherbetweencountriesorspecialities,andpursueour
missionacrossoncology,worldwide.
TheESMOcommunitybringstogethermorethan16,000oncologyprofessionalsfromover130countries.Drawingon40yearsof
experienceandaround500expertcommitteemembers,ESMOservesitsmembersandtheoncologycommunitythrough:
• Post-graduateoncologyeducationandtraining
• Careerdevelopmentandleadershiptrainingforthenextgenerationsofoncologists
• Internationalcongressesandworkshopstoshareexpertiseandbestpractice,learnaboutthemostup-to-datescientificadvances,
andconnectwithcolleaguesinrelateddisciplines.
• Continuouslyreviewed,evidence-basedstandardsforcancercareinEurope
• Advocacyandconsultationtofosterafavourableenvironmentforscientificresearch
Cancercareisrapidlybecomingmoreintegratedandmorespecialised;whethertheirfieldisresearch,diagnosis,treatment,care,or
advocacy,oncologyprofessionalsneedtobothbuildtheirspecialistknowledgeandconnectwiththebestpractitionersinotherdisci-
plinesworldwide.ESMOmembershipmakesthispossible.
Pleasevisitesmo.orgtolearnmore.AcrossOncology.Worldwide.
The European Association for Cancer Research (EACR)
TheEuropeanAssociationforCancerResearchisaprofessionalmembershipsocietyforcancerresearcherswithmorethan10,000
membersworldwide.TheEACRwasfoundedin1968andhasoneguidingaim:‘Theadvancementofcancerresearchforthepublic
benefit’.Membershipisopentoanyoneactivelyworkingorstudyingincancerresearch.Ourmembersworkacrossthefullspectrumof
thefield,frombasicthroughtotranslationalandclinicalresearch,andrangefrompostgraduatestudentstowinnersoftheNobelPrize.
Researcherswhoaremembersofoneofthe14EACRaffiliated‘NationalSocieties’automaticallybecomemembersoftheEACRas
partofthewiderbenefitsofbelongingtotheirnationalsociety.Themembershipfeeforactivemembersisjust40Eurosperannumor
120Eurosfor4years,andspecialreducedmembershipfeesareavailabletopostgraduatestudentsandthosewithlessthan4years’post-
doctoralexperience.
Wefacilitatecommunicationandcollaborationwithinthecancerresearchcommunity.Wealsosetouttoraisetheprofileofcancer
researchinEuropeandtomakethecaseforsustainedpoliticalandeconomicsupport.Weorganisescientificconferencesofthehighest
quality,opentomembersandnon-members.OurConferenceSeriesofsmall,focusedmeetingsishighlyregardedforitsfocusonthe
latestresearchtopicsandfortheprovisionofopportunitiesforinteractionbetweenspeakersandparticipants.In2018wewillcelebrate
our50thanniversaryandinviteyoutojoinusatEACR25,ourbiennialCongresstobeheldinAmsterdam,Netherlands,30June-03
July2018.
FindoutmoreabouttheEACRatwww.eacr.org
ESMO Executive Board
President FortunatoCiardiello,Naples,Italy
President-Elect JosepTabernero,Barcelona,Spain
PastPresidentandMembershipCommitteeChair RolfA.Stahel,Zurich,Switzerland
Treasurer EmileVoest,Amsterdam,Netherlands
EducationalCommitteeChair Andre´sCervantes,Valencia,Spain
NationalRepresentativesandMembershipCommitteeChair FatimaCardoso,Lisbon,Portugal
EUPolicyCommitteeChair PaoloG.Casali,Milan,Italy
GlobalPolicyCommitteeChair AlexandruEniu,Cluj-Napoca,Romania
GuidelinesWorkingGroupChair GeorgePentheroudakis,Ioannina,Greece
PressandMediaAffairsCommitteeChair SolangePeters,Lausanne,Switzerland
BoardMember DirkArnold,Lisbon,Portugal
BoardMember SusanaBanerjee,London,UnitedKingdom
BoardMember AlexanderM.M.Eggermont,Villejuif,France
BoardMember SumitraThongprasert,Bangkok,Thailand
BoardMember ChristophZielinski,Vienna,Austria
EACR Executive Board
President AntonBerns,Amsterdam,Netherlands
PresidentElect AlbertoBardelli,Turin,Italy
PastPresident RichardMarais,Manchester,UK
SecretaryGeneral JoanSeoane,Barcelona,Spain
Treasurer ChristofvonKalle,Heidelberg,Germany
Member CarlosCaldas,Cambridge,UK
Member LeonorDavid,Porto,Portugal
Member CarolineDive,Manchester,UK
Member DanielPeeper,Amsterdam,Netherlands
Member YardenaSamuels,Rehovot,Israel
Member EmmyVerschuren,Helsinki,Finland
RepresentativeforEarlyCareerResearchers EliPikarsky,Jerusalem,Israel
RepresentativeforEarlyCareerResearchers ThereseSørlie,Oslo,Norway
ESMO 2017 Congress Officers
ESMOandCongressPresident
FortunatoCiardiello,Naples,Italy
ScientificCommitteeCo-Chairs
AlbertoSobrero,Genoa,Italy(ESMO)
RichardMarais,Manchester,UK(EACR)
EducationalChair
Andre´sCervantes,Valencia,Spain
PressOfficer
SolangePeters,Lausanne,Switzerland
LocalOfficer
MiguelMartin,Madrid,Spain
ScientificCommittee
Basicscience Breastcancer,earlystage
Chairs:AntonBerns,Amsterdam,Netherlandsand Chair:NadiaHarbeck,Munich,Germany
ChristofvonKalle,Heidelberg,Germany HerveBonnefoi,Bordeaux,France
AlbertoBardelli,Candiolo,Italy FatimaCardoso,Lisbon,Portugal
RaffaeleCalifano,Manchester,UK MarcoColleoni,Milan,Italy
KarindeVisser,Amsterdam,Netherlands JavierCortes,Madrid,Spain
KristianHelin,Copenhagen,Denmark CarlosCaldas,Cambridge,UK
DavidHuntsman,Vancouver,BC,Canada CarstenDenkert,Berlin,Germany
ClareIsacke,Cambridge,UK AngelodiLeo,Prato,Italy
RichardMarais,Manchester,UK DougEaston,Cambridge,UK
UltanMcDermott,Cambridge,UK MichaelGnant,Vienna,Austria
PierGuiseppePelicci,Milan,Italy JosJonkers,Amsterdam,Netherlands
DavidTuveson,ColdSpringHarbor,NY,USA OliviaPagani,Bellinzona,Switzerland
ElzbietaSenkus,Gdan(cid:2)sk,Poland
AndrewTutt,London,UK
Breastcancer,metastatic CNStumours
Chair:FabriceAndre´,Villejuif,France Chair:MichaelWeller,Zurich,Switzerland
JoanAlbanell,Barcelona,Spain CarmenBalan~a,Barcelona,Spain
ThomasBachelot,Lyon,France AlbaBrandes,Bologna,Italy
FatimaCardoso,Lisbon,Portugal LouisChesler,London,UK
RobClarke,Philadelphia,PA,USA PimFrench,Rotterdam,Netherlands
ShereneLoi,Melbourne,Australia EmilieLeRhun,Lille,France
SibylleLoibl,Neu-Isenburg,Germany RogerHenriksson,Stockholm,Sweden
FrederiquePenault-Llorca,Clermont-Ferrand,France StefanPfister,Hedielberg,Germany
AleixPrat,Barcelona,Spain MatthiasPreusser,Vienna,Austria
RomanRouzier,Paris,France Jo¨rg-ChristianTonn,Munich,Germany
PeterSchmid,London,UK MartinvandenBent,Rotterdam,Netherlands
BrittaWeigelt,NewYork,NY,USA PatrickWen,Boston,MA,USA
LucyYates,Cambridge,UK WolfgangWick,Heidelberg,Germany
Developmentaltherapeutics Gastrointestinaltumours,colorectal
Chair:JanSchellens,Amsterdam,Netherlands Chair:VolkerHeinemann,Munich,Germany
AlexA.Adjei,Rochester,MN,USA RichardAdams,Cardiff,UK
UdaiBanerji,London,UK DirkArnold,Lisbon,Portugal
ChristianBlank,Amsterdam,Netherlands Andre´sCervantes,Valencia,Spain
AnthonyChalmers,Glasgow,UK AlfredoFalcone,Pisa,Italy
MariaGraziaDaidone,Milan,Italy GunnarFolprecht,Dresden,Germany
AntoineItaliano,Bordeaux,France RobGlynne-Jones,Northwood,UK
UlrikLassen,Copenhagen,Denmark ThomasGruenberger,Vienna,Austria
IgnacioMelero,Pamplona,Spain RienkOffringa,Heidelberg,Germany
RuthPlummer,NewcastleuponTyne,UK PerPfeiffer,Odense,Denmark
JordiRodo(cid:2)n,Houston,TX,USA OwenSansom,Glasgow,UK
TeresaTroiani,Naples,Italy JulienTaieb,Paris,France
IanWaddell,Manchester,UK VincenzoValentini,Rome,Italy
Gastrointestinaltumours,non-colorectal Genitourinarytumours,prostate
Chair:EricVanCutsem,Leuven,Belgium Chair:JohanndeBono,Sutton,UK
FatimaCarneiro,Porto,Portugal AndreaAlimonti,Bellinzona,Switzerland
StefanoCascinu,Modena,Italy EstherBaena,Manchester,UK
DavidCunningham,Sutton,UK HimishaBeltran,NewYork,NY,USA
ManuelHidalgo,Madrid,Spain WinaldGerritsen,Nijmegen,Netherlands
ClausJorgensen,Manchester,UK SilkeGillessen,St.Gallen,Switzerland
Yoon-KooKang,Seoul,RepublicofKorea NicholasJames,Birmingham,UK
FlorianLordick,Leipzig,Germany VesaKataja,Jyv€askyl€a,Finland
ChristopheMariette†,Lille,France DavidLorente,Valencia,Spain
ArnaudRoth,Geneva,Switzerland DavidOlmos,Madrid,Spain
DieterSaur,Munich,Germany StephaneOudard,Paris,France
ThomasSeufferlein,Ulm,Germany ScottTomlins,AnnArbor,MI,USA
MarcelVerhej,Amsterdam,Netherlands DavidWaugh,Belfast,UK
MarcYchou,Montpellier,France
Genitourinarytumours,non-prostate Gynaecologicalcancers
Chair:BernardEscudier,Villejuif,France Chair:DomenicaLorusso,Milan,Italy
CoryAbate-Shen,NewYork,NY,USA FredericAmant,Leuven,Belgium
LaurenceAlbiges,Villejuif,France SusanaBanerjee,London,UK
ArisBamias,Athens,Greece AntonioGonz(cid:2)alez-Mart(cid:2)ın,Madrid,Spain
AxelBex,Amsterdam,Netherlands PhilippHarter,Essen,Germany
PetriBono,Helsinki,Finland MansoorMirza,Copenhagen,Denmark
FernandoCalaisdaSilva,Lisbon,Portugal RemiANout,Leiden,Netherlands
MariaDeSantis,Coventry,UK SandroPignata,Naples,Italy
KarimFizazi,Villejuif,France JamiePrat,Barcelona,Spain
VincentKhoo,London,UK IsabelleRay-Coquard,Lyon,France
AntonioLo(cid:2)pez-Beltran,Lisbon,Portugal IgnaceVergote,Leuven,Belgium
AndreaNecchi,Milan,Italy
CamilloPorta,Pavia,Italy
MichaelStaehler,Munich,Germany
Haematologicalmalignancies Headandneckcancer
Chair:MarianoProvencio,Madrid,Spain Chair:Jean-PascalMachiels,Brussels,Belgium
ChristianBuske,Ulm,Germany AmparoCano,Madrid,Spain
MariadelMarCo(cid:2)rdoba,Madrid,Spain IsabelFonseca,Lisbon,Portugal
Andre´sFerreri,Milan,Italy VincentGre´goire,Brussels,Belgium
JuanFernandoGarcia,Madrid,Spain JoelGuigay,Nice,France
PaoloGhia,Milan,Italy ChristopheLeTourneau,Paris,France
MicheleGhielmini,Bellinzona,Switzerland LisaLicitra,Milan,Italy
Jose´GomezCodina,Valencia,Spain MarcoMerlano,Cuneo,Italy
MarcoLadetto,Alessandria,Italy RicardoMesia,Barcelona,Spain
StevenLeGouill,Nantes,France SjoukjeOosting,Groningen,Netherlands
FredericPeyrade,Nice,France AmandaPsyrri,Athens,Greece
TimSomervaille,Manchester,UK Hans-PeterRodemann,Tu¨bingen,Germany
EvangelosTerpos,Athens,Greece ChristianSimon,Lausanne,Switzerland
AndreasTrumpp,Heidelberg,Germany
Immunotherapyofcancer Melanomaandotherskintumours
Chair:IngeMarieSvane,Herlev,Denmark Chair:ReinhardDummer,Zurich,Switzerland
MarioColombo,Milan,Italy PaoloAscierto,Naples,Italy
GeorgeCoukos,Lausanne,Switzerland BorisBastian,SanFrancisco,CA,USA
Je´roˆmeGalon,Paris,France MatthiasGuckenberger,Zurich,Switzerland
HelenGogas,Athens,Greece PaulLorigan,Manchester,UK
JohnHaanen,Amsterdam,Netherlands SalvadorMartin-Algarra,Pamplona,Spain
GuidoKroemer,Paris,France OlivierMichielin,Lausanne,Switzerland
PaulNathan,Northwood,UK DanielPeeper,Amsterdam,Netherlands
EliPikarsky,Jerusalem,Israel AntoniRibas,LosAngeles,CA,USA
ThomasPowles,London,UK CarolineRobert,Villejuif,France
DanielSpeiser,Lausanne,Switzerland YardenaSamuels,Rehovot,Istrael
FionaThistlethwaite,Manchester,UK DirkSchadendorf,Essen,Germany
AlessandroTestori,Milan,Italy
NETsandendocrinetumours Non-metastaticNSCLCandotherthoracic
Chair:MichelDucreux,Villejuif,France malignancies
EricBaudin,Villejuif,France Chair:PilarGarrido,Madrid,Spain
JeromeBertherat,Paris,France PaulBaas,Amsterdam,Netherlands
FelixBeuschlein,Munich,Germany MarianoBarbacid,Madrid,Spain
JaumeCapdevila,Barcelona,Spain Anne-MarieDingemans,Maastricht,Netherlands
IanChau,Sutton,UK MarinaGarassino,Milan,Italy
RocioGarcia-Carbonero,Madrid,Spain Ce´cileLePe´choux,Villejuif,France
DikKwekkeboom†,Rotterdam,Netherlands KeunchilPark,Seoul,RepublicofKorea
MariannePavel,Erlangen,Germany LuisPaz-Ares,Madrid,Spain
GuidoRindi,Rome,Italy SanjayPopat,London,UK
EnricoRuffini,Turin,Italy EgbertSmit,Amsterdam,Netherlands
JonathanStrosberg,Tampa,FL,USA PaulVanSchil,Edegem,Belgium
JohanVansteenkiste,Leuven,Belgium
EmmyVerschuren,Helsinki,Finland